Women Now Outnumber Men in Cannabis Use — And They're Changing the Market

Something historic happened in the cannabis market in 2026 that almost no one saw coming: for the first time in recorded history, young women aged 19–30 consume more cannabis than men in the same age group. The gender gap that defined cannabis use for decades — men as the dominant consumer, women as the secondary market — has flipped.

The shift was documented in CNN chief medical correspondent Dr. Sanjay Gupta's "Weed 8: Women and Weed," which premiered April 19, 2026, and quickly became one of the most-discussed cannabis documentaries since his original Weed special in 2013. But the trend itself runs deeper than a single documentary.

The Data Behind the Shift

The numbers are unambiguous. Women now account for more than half of all cannabis consumers in the United States. In the 19–30 age bracket, women have overtaken men as the dominant demographic — a reversal of every survey and consumption study going back decades. Among middle-aged and older adults, women are also outpacing men at a faster growth rate than any other demographic segment.

The behavioral profile of female cannabis consumers in 2026 is meaningfully different from the historical stoner archetype. Women purchase an average of three items per dispensary visit compared to 2.7 for men, and have a slightly higher average order value ($54.37 vs. $53.29). They shop more deliberately, choose more varied product formats, and are significantly more likely to purchase tinctures, capsules, topicals, and low-dose edibles over high-THC flower.

What's Driving the Shift

Dr. Gupta's documentary frames the change through a compelling lens: women are turning to cannabis because the conventional medical system has repeatedly failed them. From chronic pain dismissed as anxiety, to reproductive health issues undertreated for decades, to mental health struggles disproportionately shouldered by young women in a high-stress cultural moment — cannabis is filling a gap that traditional medicine left open.

"They tried everything, and nothing worked," Gupta wrote in a companion essay for CNN. "Now, women are turning to cannabis for help."

The specific use cases skew toward wellness over recreation:

Chronic pain management is a primary driver, particularly for conditions like endometriosis, fibromyalgia, and migraine, which disproportionately affect women and are historically undertreated.

Sleep is the second most common use case. Women in the 30–55 age range, in particular, are seeking cannabis as a non-pharmaceutical sleep aid, especially as an alternative to benzodiazepines or ambien.

Anxiety and stress relief remain the top reported reasons across all age groups, though the Lancet Psychiatry systematic review published earlier in 2026 found limited clinical evidence for efficacy — a nuance that hasn't dampened consumer demand.

Perimenopause and menopause are emerging as major drivers among women over 45, with many reporting that cannabis helps manage hot flashes, mood changes, and sleep disruption. This segment is growing rapidly, with very little clinical research to guide it.

The "Cannamom" Movement

One of the most culturally significant phenomena Dr. Gupta's documentary captures is the rise of "Cannamoms" — communities of women, often mothers, who gather socially to consume cannabis, share experiences, and exchange information about products and dosing. Think book club meets wellness circle, with gummies and tinctures on the table instead of wine.

The Cannamom phenomenon is meaningful beyond its social novelty. It represents a normalization of cannabis consumption among demographics that were previously entirely outside the market, and it's driving product innovation. Low-dose, fast-acting, discreet products — infused sparkling water, micro-dose capsules, sublingual strips — are growing because that's what this consumer wants.

The social and communal aspect also matters for information sharing. In the absence of clinical guidance, women are teaching each other about dosing, timing, product selection, and managing the health conditions they use cannabis for. This peer network is, in many markets, more effective at education than any dispensary or health system.

What the Industry Is (and Isn't) Doing About It

Cannabis marketing has historically been male-coded — the Cheech and Chong trope, the "dude" aesthetic, the emphasis on getting as high as possible. That's changing, but not fast enough. Brands that have pivoted toward wellness framing, premium aesthetics, and female-forward branding are capturing disproportionate growth.

Dispensaries that have invested in knowledgeable staff, consultation-style sales processes, and product education are significantly outperforming those that still sell cannabis the way a gas station sells beer.

What the industry hasn't done well is research. There is almost no quality clinical data on how cannabis interacts with female physiology — hormone cycles, pregnancy, menopause, the specific conditions women most commonly treat. The general prohibition on cannabis research that the DEA's rescheduling is beginning to dismantle has left a particularly large gap for women's health applications.

A Market Transformation in Real Time

The rise of women as the dominant cannabis demographic isn't just a cultural story. It's a market transformation with direct commercial implications. Brands that continue to market predominantly to young men are leaving the majority of the market on the table. Dispensaries that haven't updated their staff training, product mix, and customer experience for a wellness-oriented female consumer are ceding ground to competitors that have.

The most successful cannabis retailers in 2026 look less like head shops and more like Sephora stores — clean, consultative, education-forward, and built around the customer's desired outcome rather than the highest THC number on the shelf.

Key Takeaways

• For the first time, women aged 19–30 consume more cannabis than men; women now account for over half of all U.S. cannabis consumers
• Primary use cases skew toward wellness: chronic pain, sleep, anxiety, perimenopause — often for conditions undertreated by conventional medicine
• Women purchase more items per visit and have higher average order values than male consumers
• The "Cannamom" community has emerged as a powerful force for normalization and peer education
• Cannabis brands and dispensaries are still catching up to this demographic shift; those that adapt earliest have a significant competitive advantage

Explore wellness-focused cannabis products and find expert dispensaries at Budpedia.